·1 хв читання · 65 слів·👁 8.0K↗ 15
New data shows GSK-Vir drug works against all Omicron mutations
The data, yet to be published in a peer-reviewed medical journal, shows that the companies' treatment, sotrovimab, is effective against all 37 identified mutations to date in the spike protein, GSK said in a statement.
Last week, another set of pre-clinical data showed that the drug had worked against key mutations of the Omicron variant.
